25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Jintian Pharmaceutical Grp Ltd
Buy, Hold or Sell?

Let's analyze Jintian Pharmaceutical Grp Ltd together

I guess you are interested in Jintian Pharmaceutical Grp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jintian Pharmaceutical Grp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Jintian Pharmaceutical Grp Ltd

I send you an email if I find something interesting about Jintian Pharmaceutical Grp Ltd.

1. Quick Overview

1.1. Quick analysis of Jintian Pharmaceutical Grp Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Jintian Pharmaceutical Grp Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
27.3%

What is your share worth?

Current worth
HK$0.43
Expected worth in 1 year
HK$-0.08
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
HK$-0.51
Return On Investment
-383.4%

For what price can you sell your share?

Current Price per Share
HK$0.13
Expected price per share
HK$0.091 - HK$0.169
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Jintian Pharmaceutical Grp Ltd (5 min.)




Live pricePrice per Share (EOD)
HK$0.13
Intrinsic Value Per Share
HK$-2.69 - HK$9.25
Total Value Per Share
HK$-2.26 - HK$9.68

2.2. Growth of Jintian Pharmaceutical Grp Ltd (5 min.)




Is Jintian Pharmaceutical Grp Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$44.2m$57.4m-$13.1m-29.7%

How much money is Jintian Pharmaceutical Grp Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$14.8m-$26.4m$11.5m78.0%
Net Profit Margin-8.1%-14.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Jintian Pharmaceutical Grp Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  


Richest
#26 / 41

Most Revenue
#19 / 41

Most Profit
#39 / 41
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Jintian Pharmaceutical Grp Ltd?

Welcome investor! Jintian Pharmaceutical Grp Ltd's management wants to use your money to grow the business. In return you get a share of Jintian Pharmaceutical Grp Ltd.

First you should know what it really means to hold a share of Jintian Pharmaceutical Grp Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jintian Pharmaceutical Grp Ltd is HK$0.133. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jintian Pharmaceutical Grp Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jintian Pharmaceutical Grp Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.43. Based on the TTM, the Book Value Change Per Share is HK$-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jintian Pharmaceutical Grp Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.02-13.9%-0.02-13.9%-0.03-24.8%-0.06-45.6%-0.03-20.9%
Usd Book Value Change Per Share-0.02-12.3%-0.02-12.3%-0.03-22.0%-0.01-5.2%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.001.1%
Usd Total Gains Per Share-0.02-12.3%-0.02-12.3%-0.03-22.0%-0.01-5.2%0.001.1%
Usd Price Per Share0.02-0.02-0.02-0.02-0.10-
Price to Earnings Ratio-0.81--0.81--0.60--0.41-4.07-
Price-to-Total Gains Ratio-0.92--0.92--0.68--0.36--1.27-
Price to Book Ratio0.27-0.27-0.28-0.17-0.56-
Price-to-Total Gains Ratio-0.92--0.92--0.68--0.36--1.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0171171
Number of shares58421
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share-0.02-0.01
Gains per Quarter (58421 shares)-958.57-401.67
Gains per Year (58421 shares)-3,834.27-1,606.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3834-38440-1607-1617
20-7669-76780-3213-3224
30-11503-115120-4820-4831
40-15337-153460-6427-6438
50-19171-191800-8033-8045
60-23006-230140-9640-9652
70-26840-268480-11247-11259
80-30674-306820-12853-12866
90-34508-345160-14460-14473
100-38343-383500-16067-16080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.08.00.027.3%4.08.02.028.6%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.08.00.027.3%5.09.00.035.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%3.00.08.027.3%4.00.010.028.6%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.08.00.027.3%5.09.00.035.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Jintian Pharmaceutical Grp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.127-0.1270%-0.228+79%-0.053-58%0.000-441327%
Book Value Per Share--0.4300.4300%0.557-23%1.168-63%1.229-65%
Current Ratio--0.9190.9190%1.061-13%2.162-57%3.907-76%
Debt To Asset Ratio--0.5740.5740%0.514+12%0.358+60%0.248+131%
Debt To Equity Ratio--1.3481.3480%1.056+28%0.685+97%0.416+224%
Dividend Per Share----0%-0%-0%0.011-100%
Eps---0.144-0.1440%-0.256+78%-0.471+227%-0.216+50%
Free Cash Flow Per Share---0.025-0.0250%-0.058+133%-0.269+984%-0.092+271%
Free Cash Flow To Equity Per Share---0.009-0.0090%0.018-152%-0.252+2559%-0.059+518%
Gross Profit Margin--1.0001.0000%1.0000%1.666-40%-1.004+200%
Intrinsic Value_10Y_max--9.250--------
Intrinsic Value_10Y_min---2.686--------
Intrinsic Value_1Y_max--0.139--------
Intrinsic Value_1Y_min---0.272--------
Intrinsic Value_3Y_max--1.019--------
Intrinsic Value_3Y_min---0.820--------
Intrinsic Value_5Y_max--2.622--------
Intrinsic Value_5Y_min---1.366--------
Market Cap106540975.744+12%93724016.25693724016.2560%123363235.072-24%102535675.904-9%1381643667.631-93%
Net Profit Margin---0.081-0.0810%-0.147+81%-0.247+204%-0.134+65%
Operating Margin---0.068-0.0680%-0.133+96%-0.207+204%-0.076+12%
Operating Ratio--1.9011.9010%1.972-4%1.715+11%1.428+33%
Pb Ratio0.310+12%0.2720.2720%0.276-1%0.174+57%0.559-51%
Pe Ratio-0.925-14%-0.813-0.8130%-0.601-26%-0.413-49%4.065-120%
Price Per Share0.133+12%0.1170.1170%0.154-24%0.128-9%0.764-85%
Price To Free Cash Flow Ratio-5.350-14%-4.707-4.7070%-2.653-44%-1.797-62%2.699-274%
Price To Total Gains Ratio-1.043-14%-0.918-0.9180%-0.676-26%-0.356-61%-1.270+38%
Quick Ratio--0.3210.3210%0.399-20%1.091-71%1.759-82%
Return On Assets---0.143-0.1430%-0.224+57%-0.307+115%-0.173+22%
Return On Equity---0.335-0.3350%-0.460+37%-0.504+50%-0.266-20%
Total Gains Per Share---0.127-0.1270%-0.228+79%-0.053-58%0.011-1233%
Usd Book Value--44288706.70244288706.7020%57432431.036-23%120371764.961-63%242121859.860-82%
Usd Book Value Change Per Share---0.016-0.0160%-0.029+79%-0.007-58%0.000-441327%
Usd Book Value Per Share--0.0550.0550%0.072-23%0.150-63%0.158-65%
Usd Dividend Per Share----0%-0%-0%0.001-100%
Usd Eps---0.019-0.0190%-0.033+78%-0.061+227%-0.028+50%
Usd Free Cash Flow---2562803.203-2562803.2030%-5983861.223+133%-27778580.221+984%-7177006.715+180%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.007+133%-0.035+984%-0.012+271%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.002-152%-0.032+2559%-0.008+518%
Usd Market Cap13711823.578+12%12062280.89212062280.8920%15876848.354-24%13196341.489-9%177817540.024-93%
Usd Price Per Share0.017+12%0.0150.0150%0.020-24%0.016-9%0.098-85%
Usd Profit---14831526.970-14831526.9700%-26405794.675+78%-48561940.411+227%-31012743.402+109%
Usd Revenue--182519658.201182519658.2010%179217790.512+2%216437201.869-16%386383532.535-53%
Usd Total Gains Per Share---0.016-0.0160%-0.029+79%-0.007-58%0.001-1233%
 EOD+5 -3MRQTTM+0 -0YOY+20 -135Y+15 -1910Y+17 -19

3.3 Fundamental Score

Let's check the fundamental score of Jintian Pharmaceutical Grp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.925
Price to Book Ratio (EOD)Between0-10.310
Net Profit Margin (MRQ)Greater than0-0.081
Operating Margin (MRQ)Greater than0-0.068
Quick Ratio (MRQ)Greater than10.321
Current Ratio (MRQ)Greater than10.919
Debt to Asset Ratio (MRQ)Less than10.574
Debt to Equity Ratio (MRQ)Less than11.348
Return on Equity (MRQ)Greater than0.15-0.335
Return on Assets (MRQ)Greater than0.05-0.143
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Jintian Pharmaceutical Grp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.323
Ma 20Greater thanMa 500.127
Ma 50Greater thanMa 1000.094
Ma 100Greater thanMa 2000.084
OpenGreater thanClose0.127
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Jintian Pharmaceutical Grp Ltd

Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, prepackaged foods, nutritional foods, health care products, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; and dairy products, including infant formula milk powder. The company also provides storage services. The company was formerly known as Jintian Pharmaceutical Group Limited and changed its name to Universal Health International Group Holding Limited in July 2015. Universal Health International Group Holding Limited was founded in 1998 and is headquartered in Shenyang, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-10-29 09:06:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Jintian Pharmaceutical Grp Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of -8.1% means that $-0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is -8.1%. The company is making a loss. -1
  • The TTM is -8.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-8.1%TTM-8.1%0.0%
TTM-8.1%YOY-14.7%+6.6%
TTM-8.1%5Y-24.7%+16.5%
5Y-24.7%10Y-13.4%-11.3%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.1%1.0%-9.1%
TTM-8.1%0.7%-8.8%
YOY-14.7%1.0%-15.7%
5Y-24.7%1.6%-26.3%
10Y-13.4%1.5%-14.9%
4.3.1.2. Return on Assets

Shows how efficient Jintian Pharmaceutical Grp Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • -14.3% Return on Assets means that Jintian Pharmaceutical Grp Ltd generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is -14.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.3%TTM-14.3%0.0%
TTM-14.3%YOY-22.4%+8.1%
TTM-14.3%5Y-30.7%+16.4%
5Y-30.7%10Y-17.3%-13.3%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.3%0.4%-14.7%
TTM-14.3%0.4%-14.7%
YOY-22.4%0.3%-22.7%
5Y-30.7%0.3%-31.0%
10Y-17.3%0.3%-17.6%
4.3.1.3. Return on Equity

Shows how efficient Jintian Pharmaceutical Grp Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • -33.5% Return on Equity means Jintian Pharmaceutical Grp Ltd generated $-0.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is -33.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.5%TTM-33.5%0.0%
TTM-33.5%YOY-46.0%+12.5%
TTM-33.5%5Y-50.4%+16.9%
5Y-50.4%10Y-26.6%-23.7%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.5%1.4%-34.9%
TTM-33.5%1.0%-34.5%
YOY-46.0%1.6%-47.6%
5Y-50.4%1.8%-52.2%
10Y-26.6%0.8%-27.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Jintian Pharmaceutical Grp Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Jintian Pharmaceutical Grp Ltd is operating .

  • Measures how much profit Jintian Pharmaceutical Grp Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of -6.8% means the company generated $-0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is -6.8%. The company is operating very inefficient. -2
  • The TTM is -6.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-6.8%TTM-6.8%0.0%
TTM-6.8%YOY-13.3%+6.5%
TTM-6.8%5Y-20.7%+13.9%
5Y-20.7%10Y-7.6%-13.1%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.8%2.7%-9.5%
TTM-6.8%1.4%-8.2%
YOY-13.3%1.5%-14.8%
5Y-20.7%1.4%-22.1%
10Y-7.6%1.3%-8.9%
4.3.2.2. Operating Ratio

Measures how efficient Jintian Pharmaceutical Grp Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.90 means that the operating costs are $1.90 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is 1.901. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.901. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.901TTM1.9010.000
TTM1.901YOY1.972-0.071
TTM1.9015Y1.715+0.186
5Y1.71510Y1.428+0.287
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9011.493+0.408
TTM1.9011.246+0.655
YOY1.9721.147+0.825
5Y1.7151.174+0.541
10Y1.4281.185+0.243
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Jintian Pharmaceutical Grp Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Jintian Pharmaceutical Grp Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 0.92 means the company has $0.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is 0.919. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.919. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.919TTM0.9190.000
TTM0.919YOY1.061-0.141
TTM0.9195Y2.162-1.243
5Y2.16210Y3.907-1.745
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9191.259-0.340
TTM0.9191.270-0.351
YOY1.0611.161-0.100
5Y2.1621.315+0.847
10Y3.9071.443+2.464
4.4.3.2. Quick Ratio

Measures if Jintian Pharmaceutical Grp Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.32 means the company can pay off $0.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is 0.321. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.321. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.321TTM0.3210.000
TTM0.321YOY0.399-0.078
TTM0.3215Y1.091-0.770
5Y1.09110Y1.759-0.668
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3210.505-0.184
TTM0.3210.546-0.225
YOY0.3990.536-0.137
5Y1.0910.641+0.450
10Y1.7590.881+0.878
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Jintian Pharmaceutical Grp Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Jintian Pharmaceutical Grp Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.57 means that Jintian Pharmaceutical Grp Ltd assets are financed with 57.4% credit (debt) and the remaining percentage (100% - 57.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is 0.574. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.574. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.574TTM0.5740.000
TTM0.574YOY0.514+0.060
TTM0.5745Y0.358+0.216
5Y0.35810Y0.248+0.110
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5740.638-0.064
TTM0.5740.651-0.077
YOY0.5140.690-0.176
5Y0.3580.640-0.282
10Y0.2480.600-0.352
4.5.4.2. Debt to Equity Ratio

Measures if Jintian Pharmaceutical Grp Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 134.8% means that company has $1.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The MRQ is 1.348. The company is able to pay all its debts with equity. +1
  • The TTM is 1.348. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.348TTM1.3480.000
TTM1.348YOY1.056+0.292
TTM1.3485Y0.685+0.662
5Y0.68510Y0.416+0.269
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3481.607-0.259
TTM1.3481.745-0.397
YOY1.0562.145-1.089
5Y0.6851.982-1.297
10Y0.4161.661-1.245
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Jintian Pharmaceutical Grp Ltd generates.

  • Above 15 is considered overpriced but always compare Jintian Pharmaceutical Grp Ltd to the Pharmaceutical Retailers industry mean.
  • A PE ratio of -0.81 means the investor is paying $-0.81 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The EOD is -0.925. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.813. Based on the earnings, the company is expensive. -2
  • The TTM is -0.813. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.925MRQ-0.813-0.111
MRQ-0.813TTM-0.8130.000
TTM-0.813YOY-0.601-0.212
TTM-0.8135Y-0.413-0.400
5Y-0.41310Y4.065-4.478
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-0.92510.142-11.067
MRQ-0.81312.431-13.244
TTM-0.8139.431-10.244
YOY-0.60111.917-12.518
5Y-0.4136.490-6.903
10Y4.06514.310-10.245
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The EOD is -5.350. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.707. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.707. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.350MRQ-4.707-0.644
MRQ-4.707TTM-4.7070.000
TTM-4.707YOY-2.653-2.053
TTM-4.7075Y-1.797-2.909
5Y-1.79710Y2.699-4.497
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-5.3502.404-7.754
MRQ-4.7072.425-7.132
TTM-4.7072.438-7.145
YOY-2.6533.326-5.979
5Y-1.7972.868-4.665
10Y2.6990.118+2.581
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Jintian Pharmaceutical Grp Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 0.27 means the investor is paying $0.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Jintian Pharmaceutical Grp Ltd:

  • The EOD is 0.310. Based on the equity, the company is cheap. +2
  • The MRQ is 0.272. Based on the equity, the company is cheap. +2
  • The TTM is 0.272. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.310MRQ0.272+0.037
MRQ0.272TTM0.2720.000
TTM0.272YOY0.276-0.004
TTM0.2725Y0.174+0.098
5Y0.17410Y0.559-0.385
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD0.3101.134-0.824
MRQ0.2721.284-1.012
TTM0.2721.466-1.194
YOY0.2761.299-1.023
5Y0.1741.919-1.745
10Y0.5592.980-2.421
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Other Stockholders Equity  -148,134-25,007-173,1417,184-165,957998-164,9592,071,6311,906,672
Net Working Capital  1,113,112-638,529474,583-361,216113,367-87,53825,829-59,783-33,953
Net Interest Income  3,432-2,793640-56772741813-1,453-640



6.2. Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets738,864
Total Liabilities424,136
Total Stockholder Equity314,728
 As reported
Total Liabilities 424,136
Total Stockholder Equity+ 314,728
Total Assets = 738,864

Assets

Total Assets738,864
Total Current Assets352,773
Long-term Assets386,091
Total Current Assets
Cash And Cash Equivalents 42,995
Net Receivables 80,115
Inventory 164,128
Other Current Assets 59,182
Total Current Assets  (as reported)352,773
Total Current Assets  (calculated)346,420
+/- 6,353
Long-term Assets
Property Plant Equipment 212,090
Intangible Assets 4,818
Other Assets 104,486
Long-term Assets  (as reported)386,091
Long-term Assets  (calculated)321,394
+/- 64,697

Liabilities & Shareholders' Equity

Total Current Liabilities383,826
Long-term Liabilities40,310
Total Stockholder Equity314,728
Total Current Liabilities
Accounts payable 352,186
Other Current Liabilities 31,331
Total Current Liabilities  (as reported)383,826
Total Current Liabilities  (calculated)383,517
+/- 309
Long-term Liabilities
Long term Debt Total 40,310
Long-term Liabilities  (as reported)40,310
Long-term Liabilities  (calculated)40,310
+/-0
Total Stockholder Equity
Retained Earnings -1,472,660
Capital Surplus 1,830,097
Total Stockholder Equity (as reported)314,728
Total Stockholder Equity (calculated)357,437
+/- 42,709
Other
Capital Stock43,587
Cash and Short Term Investments 42,995
Common Stock Shares Outstanding 667,550
Liabilities and Stockholders Equity 738,864
Net Invested Capital 354,728
Net Tangible Assets 314,728
Net Working Capital -31,053
Property Plant and Equipment Gross 212,090



6.3. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-12-312017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-30
> Total Assets 
268,830
1,232,769
1,515,146
2,744,231
3,413,865
3,207,944
3,302,839
2,586,325
2,229,330
2,003,340
1,495,102
957,841
839,076
738,864
738,864839,076957,8411,495,1022,003,3402,229,3302,586,3253,302,8393,207,9443,413,8652,744,2311,515,1461,232,769268,830
   > Total Current Assets 
0
0
1,098,520
2,206,444
2,469,169
2,402,192
2,261,751
1,725,162
1,577,670
1,286,396
679,861
485,607
413,989
352,773
352,773413,989485,607679,8611,286,3961,577,6701,725,1622,261,7512,402,1922,469,1692,206,4441,098,52000
       Cash And Cash Equivalents 
107,025
713,257
455,916
1,564,248
1,349,231
1,333,320
1,107,329
1,063,994
929,161
628,525
131,317
33,091
57,795
42,995
42,99557,79533,091131,317628,525929,1611,063,9941,107,3291,333,3201,349,2311,564,248455,916713,257107,025
       Short-term Investments 
0
0
96,958
8,643
393,965
10,907
9,109
39,896
6,085
2,898
0
0
0
0
00002,8986,08539,8969,10910,907393,9658,64396,95800
       Net Receivables 
69,100
142,246
186,026
264,996
266,459
248,676
165,486
173,176
224,316
266,119
133,717
85,794
97,838
80,115
80,11597,83885,794133,717266,119224,316173,176165,486248,676266,459264,996186,026142,24669,100
       Other Current Assets 
6,181
67,333
87,704
96,809
382,843
227,414
217,131
162,498
114,583
86,717
101,303
74,374
54,994
59,182
59,18254,99474,374101,30386,717114,583162,498217,131227,414382,84396,80987,70467,3336,181
   > Long-term Assets 
0
0
0
0
0
0
1,041,088
0
651,660
716,944
815,241
472,234
425,087
386,091
386,091425,087472,234815,241716,944651,66001,041,088000000
       Property Plant Equipment 
2,349
18,805
46,901
75,904
120,870
103,167
252,091
292,870
278,572
255,811
363,465
248,992
222,392
212,090
212,090222,392248,992363,465255,811278,572292,870252,091103,167120,87075,90446,90118,8052,349
       Goodwill 
0
71,516
250,321
347,436
582,258
582,562
582,562
56,402
8,918
8,918
0
0
0
0
00008,9188,91856,402582,562582,562582,258347,436250,32171,5160
       Long Term Investments 
0
0
0
0
6,454
7,520
254,835
256,887
251,851
340,089
0
0
0
0
0000340,089251,851256,887254,8357,5206,4540000
       Intangible Assets 
0
91,254
104,285
96,298
221,058
93,206
-61,262
160,995
7,642
5,558
5,787
5,086
4,952
4,818
4,8184,9525,0865,7875,5587,642160,995-61,26293,206221,05896,298104,28591,2540
       Long-term Assets Other 
0
0
0
0
0
0
0
0
651,660
716,944
0
0
0
0
0000716,944651,66000000000
> Total Liabilities 
81,718
831,525
886,988
288,455
788,697
589,574
569,389
306,996
291,955
269,547
249,748
382,869
430,945
424,136
424,136430,945382,869249,748269,547291,955306,996569,389589,574788,697288,455886,988831,52581,718
   > Total Current Liabilities 
81,718
826,960
862,119
265,444
737,999
542,989
528,107
270,858
290,319
268,368
245,818
381,924
390,366
383,826
383,826390,366381,924245,818268,368290,319270,858528,107542,989737,999265,444862,119826,96081,718
       Short-term Debt 
0
0
96,958
0
295,500
166,920
154,550
0
44,858
37,941
0
0
0
0
000037,94144,8580154,550166,920295,500096,95800
       Short Long Term Debt 
0
0
0
0
295,500
166,920
154,550
0
44,858
37,941
0
0
0
0
000037,94144,8580154,550166,920295,5000000
       Accounts payable 
52,236
86,591
141,292
93,762
270,859
279,203
371,926
183,455
203,503
208,323
160,309
304,390
343,511
352,186
352,186343,511304,390160,309208,323203,503183,455371,926279,203270,85993,762141,29286,59152,236
       Other Current Liabilities 
29,482
72,456
94,398
171,682
171,640
11,745
0
87,403
17,735
4,043
22,034
18,929
7,826
31,331
31,3317,82618,92922,0344,04317,73587,403011,745171,640171,68294,39872,45629,482
   > Long-term Liabilities 
0
0
0
0
0
0
41,282
0
1,636
1,179
3,930
0
40,000
40,310
40,31040,00003,9301,1791,636041,282000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
3,930
0
40,000
40,310
40,31040,00003,9300000000000
       Other Liabilities 
0
0
0
0
50,698
46,585
41,282
36,138
1,636
1,179
0
0
0
0
00001,1791,63636,13841,28246,58550,6980000
> Total Stockholder Equity
187,112
362,457
548,781
2,354,892
2,598,159
2,588,650
2,708,689
2,259,435
1,916,956
1,730,171
1,243,798
574,972
408,131
314,728
314,728408,131574,9721,243,7981,730,1711,916,9562,259,4352,708,6892,588,6502,598,1592,354,892548,781362,457187,112
   Common Stock
0
0
0
12,259
12,259
12,259
14,878
17,998
19,167
22,942
24,833
24,833
35,943
43,587
43,58735,94324,83324,83322,94219,16717,99814,87812,25912,25912,259000
   Retained Earnings 
154,678
334,795
528,145
782,838
1,230,436
1,256,722
1,168,911
681,034
251,904
-12,815
-504,220
-1,115,467
-1,303,114
-1,472,660
-1,472,660-1,303,114-1,115,467-504,220-12,815251,904681,0341,168,9111,256,7221,230,436782,838528,145334,795154,678
   Capital Surplus 
0
0
0
0
1,480,656
1,405,730
1,618,899
0
1,719,133
1,791,375
1,817,387
1,817,387
1,826,170
1,830,097
1,830,0971,826,1701,817,3871,817,3871,791,3751,719,13301,618,8991,405,7301,480,6560000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
0
0
0
-185,374
-151,120
-159,058
-137,226
-138,307
-135,480
-158,351
-151,781
-150,868
1,743,801
1,743,801-150,868-151,781-158,351-135,480-138,307-137,226-159,058-151,120-185,3740000



6.4. Balance Sheets

Currency in CNY. All numbers in thousands.




6.5. Cash Flows

Currency in CNY. All numbers in thousands.




6.6. Income Statements

Currency in CNY. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-06-30. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,297,036
Cost of Revenue-1,083,190
Gross Profit213,846213,846
 
Operating Income (+$)
Gross Profit213,846
Operating Expense-1,383,041
Operating Income-98,424-1,169,195
 
Operating Expense (+$)
Research Development0
Selling General Administrative287,348
Selling And Marketing Expenses0
Operating Expense1,383,041287,348
 
Net Interest Income (+$)
Interest Income13,441
Interest Expense-1,270
Other Finance Cost-12,756
Net Interest Income-585
 
Pretax Income (+$)
Operating Income-98,424
Net Interest Income-585
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-112,105-98,424
EBIT - interestExpense = -89,596
-111,387
-104,127
Interest Expense1,270
Earnings Before Interest and Taxes (EBIT)-88,326-110,835
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-112,105
Tax Provision--5,990
Net Income From Continuing Ops-106,115-106,115
Net Income-105,397
Net Income Applicable To Common Shares-105,397
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses945
Total Other Income/Expenses Net0585
 

Technical Analysis of Jintian Pharmaceutical Grp Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jintian Pharmaceutical Grp Ltd. The general trend of Jintian Pharmaceutical Grp Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jintian Pharmaceutical Grp Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jintian Pharmaceutical Grp Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.159 < 0.169 < 0.169.

The bearish price targets are: 0.095 > 0.095 > 0.091.

Tweet this
Jintian Pharmaceutical Grp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jintian Pharmaceutical Grp Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jintian Pharmaceutical Grp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jintian Pharmaceutical Grp Ltd. The current macd is 0.01074598.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jintian Pharmaceutical Grp Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Jintian Pharmaceutical Grp Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Jintian Pharmaceutical Grp Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jintian Pharmaceutical Grp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJintian Pharmaceutical Grp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jintian Pharmaceutical Grp Ltd. The current adx is 45.58.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jintian Pharmaceutical Grp Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Jintian Pharmaceutical Grp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jintian Pharmaceutical Grp Ltd. The current sar is 0.15789588.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jintian Pharmaceutical Grp Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jintian Pharmaceutical Grp Ltd. The current rsi is 59.32. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Jintian Pharmaceutical Grp Ltd Daily Relative Strength Index (RSI) ChartJintian Pharmaceutical Grp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jintian Pharmaceutical Grp Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jintian Pharmaceutical Grp Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jintian Pharmaceutical Grp Ltd Daily Stochastic Oscillator ChartJintian Pharmaceutical Grp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jintian Pharmaceutical Grp Ltd. The current cci is 57.60.

Jintian Pharmaceutical Grp Ltd Daily Commodity Channel Index (CCI) ChartJintian Pharmaceutical Grp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jintian Pharmaceutical Grp Ltd. The current cmo is 15.12.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jintian Pharmaceutical Grp Ltd Daily Chande Momentum Oscillator (CMO) ChartJintian Pharmaceutical Grp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jintian Pharmaceutical Grp Ltd. The current willr is -54.16666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jintian Pharmaceutical Grp Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jintian Pharmaceutical Grp Ltd Daily Williams %R ChartJintian Pharmaceutical Grp Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jintian Pharmaceutical Grp Ltd.

Jintian Pharmaceutical Grp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jintian Pharmaceutical Grp Ltd. The current atr is 0.02188109.

Jintian Pharmaceutical Grp Ltd Daily Average True Range (ATR) ChartJintian Pharmaceutical Grp Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jintian Pharmaceutical Grp Ltd. The current obv is 61,645,807.

Jintian Pharmaceutical Grp Ltd Daily On-Balance Volume (OBV) ChartJintian Pharmaceutical Grp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jintian Pharmaceutical Grp Ltd. The current mfi is 46.57.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jintian Pharmaceutical Grp Ltd Daily Money Flow Index (MFI) ChartJintian Pharmaceutical Grp Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jintian Pharmaceutical Grp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Jintian Pharmaceutical Grp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jintian Pharmaceutical Grp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.323
Ma 20Greater thanMa 500.127
Ma 50Greater thanMa 1000.094
Ma 100Greater thanMa 2000.084
OpenGreater thanClose0.127
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Jintian Pharmaceutical Grp Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jintian Pharmaceutical Grp Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jintian Pharmaceutical Grp Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jintian Pharmaceutical Grp Ltd

I send you an email if I find something interesting about Jintian Pharmaceutical Grp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jintian Pharmaceutical Grp Ltd.

Receive notifications about Jintian Pharmaceutical Grp Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.